Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

120 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clinical relevance of the ESKAPE pathogens.
Pendleton JN, Gorman SP, Gilmore BF. Pendleton JN, et al. Expert Rev Anti Infect Ther. 2013 Mar;11(3):297-308. doi: 10.1586/eri.13.12. Expert Rev Anti Infect Ther. 2013. PMID: 23458769 Review.
Strategies for the development of the urinary catheter.
Hamill TM, Gilmore BF, Jones DS, Gorman SP. Hamill TM, et al. Expert Rev Med Devices. 2007 Mar;4(2):215-25. doi: 10.1586/17434440.4.2.215. Expert Rev Med Devices. 2007. PMID: 17359226 Review.
Comparison of the cidal activity of tea tree oil and terpinen-4-ol against clinical bacterial skin isolates and human fibroblast cells.
Loughlin R, Gilmore BF, McCarron PA, Tunney MM. Loughlin R, et al. Lett Appl Microbiol. 2008 Apr;46(4):428-33. doi: 10.1111/j.1472-765X.2008.02334.x. Epub 2008 Feb 22. Lett Appl Microbiol. 2008. PMID: 18298453
Antimicrobial activity of short, synthetic cationic lipopeptides.
Laverty G, McLaughlin M, Shaw C, Gorman SP, Gilmore BF. Laverty G, et al. Chem Biol Drug Des. 2010 Jun;75(6):563-9. doi: 10.1111/j.1747-0285.2010.00973.x. Epub 2010 Mar 30. Chem Biol Drug Des. 2010. PMID: 20374251
Novel inhibitors of the Pseudomonas aeruginosa virulence factor LasB: a potential therapeutic approach for the attenuation of virulence mechanisms in pseudomonal infection.
Cathcart GR, Quinn D, Greer B, Harriott P, Lynas JF, Gilmore BF, Walker B. Cathcart GR, et al. Antimicrob Agents Chemother. 2011 Jun;55(6):2670-8. doi: 10.1128/AAC.00776-10. Epub 2011 Mar 28. Antimicrob Agents Chemother. 2011. PMID: 21444693 Free PMC article.
Multihospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measures.
Aldeyab MA, Devine MJ, Flanagan P, Mannion M, Craig A, Scott MG, Harbarth S, Vernaz N, Davies E, Brazier JS, Smyth B, McElnay JC, Gilmore BF, Conlon G, Magee FA, Elhajji FW, Small S, Edwards C, Funston C, Kearney MP. Aldeyab MA, et al. Infect Control Hosp Epidemiol. 2011 Mar;32(3):210-9. doi: 10.1086/658333. Infect Control Hosp Epidemiol. 2011. PMID: 21460505
Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy.
Ryan EM, Gorman SP, Donnelly RF, Gilmore BF. Ryan EM, et al. J Pharm Pharmacol. 2011 Oct;63(10):1253-64. doi: 10.1111/j.2042-7158.2011.01324.x. Epub 2011 Jul 6. J Pharm Pharmacol. 2011. PMID: 21899540 Review.
Application of atmospheric pressure nonthermal plasma for the in vitro eradication of bacterial biofilms.
Alkawareek MY, Algwari QT, Gorman SP, Graham WG, O'Connell D, Gilmore BF. Alkawareek MY, et al. FEMS Immunol Med Microbiol. 2012 Jul;65(2):381-4. doi: 10.1111/j.1574-695X.2012.00942.x. Epub 2012 Mar 12. FEMS Immunol Med Microbiol. 2012. PMID: 22329678
Antimicrobial peptide incorporated poly(2-hydroxyethyl methacrylate) hydrogels for the prevention of Staphylococcus epidermidis-associated biomaterial infections.
Laverty G, Gorman SP, Gilmore BF. Laverty G, et al. J Biomed Mater Res A. 2012 Jul;100(7):1803-14. doi: 10.1002/jbm.a.34132. Epub 2012 Apr 4. J Biomed Mater Res A. 2012. PMID: 22489028
120 results
Jump to page
Feedback